6,494 research outputs found
Sparse integrative clustering of multiple omics data sets
High resolution microarrays and second-generation sequencing platforms are
powerful tools to investigate genome-wide alterations in DNA copy number,
methylation and gene expression associated with a disease. An integrated
genomic profiling approach measures multiple omics data types simultaneously in
the same set of biological samples. Such approach renders an integrated data
resolution that would not be available with any single data type. In this
study, we use penalized latent variable regression methods for joint modeling
of multiple omics data types to identify common latent variables that can be
used to cluster patient samples into biologically and clinically relevant
disease subtypes. We consider lasso [J. Roy. Statist. Soc. Ser. B 58 (1996)
267-288], elastic net [J. R. Stat. Soc. Ser. B Stat. Methodol. 67 (2005)
301-320] and fused lasso [J. R. Stat. Soc. Ser. B Stat. Methodol. 67 (2005)
91-108] methods to induce sparsity in the coefficient vectors, revealing
important genomic features that have significant contributions to the latent
variables. An iterative ridge regression is used to compute the sparse
coefficient vectors. In model selection, a uniform design [Monographs on
Statistics and Applied Probability (1994) Chapman & Hall] is used to seek
"experimental" points that scattered uniformly across the search domain for
efficient sampling of tuning parameter combinations. We compared our method to
sparse singular value decomposition (SVD) and penalized Gaussian mixture model
(GMM) using both real and simulated data sets. The proposed method is applied
to integrate genomic, epigenomic and transcriptomic data for subtype analysis
in breast and lung cancer data sets.Comment: Published in at http://dx.doi.org/10.1214/12-AOAS578 the Annals of
Applied Statistics (http://www.imstat.org/aoas/) by the Institute of
Mathematical Statistics (http://www.imstat.org
Joint and individual analysis of breast cancer histologic images and genomic covariates
A key challenge in modern data analysis is understanding connections between
complex and differing modalities of data. For example, two of the main
approaches to the study of breast cancer are histopathology (analyzing visual
characteristics of tumors) and genetics. While histopathology is the gold
standard for diagnostics and there have been many recent breakthroughs in
genetics, there is little overlap between these two fields. We aim to bridge
this gap by developing methods based on Angle-based Joint and Individual
Variation Explained (AJIVE) to directly explore similarities and differences
between these two modalities. Our approach exploits Convolutional Neural
Networks (CNNs) as a powerful, automatic method for image feature extraction to
address some of the challenges presented by statistical analysis of
histopathology image data. CNNs raise issues of interpretability that we
address by developing novel methods to explore visual modes of variation
captured by statistical algorithms (e.g. PCA or AJIVE) applied to CNN features.
Our results provide many interpretable connections and contrasts between
histopathology and genetics
Recommended from our members
A global transcriptional network connecting noncoding mutations to changes in tumor gene expression.
Although cancer genomes are replete with noncoding mutations, the effects of these mutations remain poorly characterized. Here we perform an integrative analysis of 930 tumor whole genomes and matched transcriptomes, identifying a network of 193 noncoding loci in which mutations disrupt target gene expression. These 'somatic eQTLs' (expression quantitative trait loci) are frequently mutated in specific cancer tissues, and the majority can be validated in an independent cohort of 3,382 tumors. Among these, we find that the effects of noncoding mutations on DAAM1, MTG2 and HYI transcription are recapitulated in multiple cancer cell lines and that increasing DAAM1 expression leads to invasive cell migration. Collectively, the noncoding loci converge on a set of core pathways, permitting a classification of tumors into pathway-based subtypes. The somatic eQTL network is disrupted in 88% of tumors, suggesting widespread impact of noncoding mutations in cancer
Evaluation of colorectal cancer subtypes and cell lines using deep learning
Colorectal cancer (CRC) is a common cancer with a high mortality rate and rising incidence rate in the developed world. Molecular profiling techniques have been used to study the variability between tumours as well as cancer models such as cell lines, but their translational value is incomplete with current methods. Moreover, first generation computational methods for subtype classification do not make use of multi-omics data in full scale. Drug discovery programs use cell lines as a proxy for human cancers to characterize their molecular makeup and drug response, identify relevant indications and discover biomarkers. In order to maximize the translatability and the clinical relevance of in vitro studies, selection of optimal cancer models is imperative. We present a novel subtype classification method based on deep learning and apply it to classify CRC tumors using multi-omics data, and further to measure the similarity between tumors and disease models such as cancer cell lines. Multi-omics Autoencoder Integration (maui) efficiently leverages data sets containing copy number alterations, gene expression, and point mutations, and learns clinically important patterns (latent factors) across these data types. Using these latent factors, we propose a refinement of the gold-standard CRC subtypes, and propose best-matching cell lines for the different subtypes. These findings are relevant for patient stratification and selection of cell lines for drug discovery pipelines, biomarker discovery, and target identification
- …